NCT06622395 Telepsychiatry in Children: Diagnostic Evaluation of Autism Spectrum Disorder
| NCT ID | NCT06622395 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier St Anne |
| Condition | Autism Spectrum Disorder (ASD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 137 participants |
| Start Date | 2022-04-29 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 137 participants in total. It began in 2022-04-29 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder recognized as a major national cause in 2012. The French Autism Plan 2018-2022 emphasizes early diagnosis and intervention for better cognitive and behavioral outcomes. The COVID-19 pandemic complicates the use of the ADOS-2 diagnostic tool due to mask-wearing and distancing requirements. To address this, the Brief Observation Symptoms of Autism (BOSA) has been adapted for remote assessment. The BOSA, translated into French, is recommended alongside the Autism Diagnostic Interview -Revised (ADI-R) for complementary diagnostic algorithms. No similar projects have been undertaken in France or Canada.
Eligibility Criteria
Inclusion Criteria: * Children aged 24 months to 5 years whose families request a diagnostic evaluation at the Autism and Related Disorders Research and Diagnostic Center (CREDAT). * Consent to participate in the research in addition to their planned evaluation at the Autism and Related Disorders Research and Diagnostic Center (CREDAT), including consent collection procedures for minors. * Sufficient understanding of the French language to complete the short version of the Autism Diagnostic Interview-Revised (ADI-R) and the Brief Observation of Symptoms of Autism (BOSA) assessment. Exclusion Criteria: * Lack of access to sufficient technology to participate in the protocol (teleconsultation). * Refusal to participate in the research. * Confirmed sensory or motor disorders (hearing or vision) that are not compensated (e.g., no glasses or hearing aids).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06622395 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 5 Years, studying Autism Spectrum Disorder (ASD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06622395 currently recruiting?
Yes, NCT06622395 is actively recruiting participants. Contact the research team at A.DEGAULMYN@ghu-paris.fr for enrollment information.
Where is the NCT06622395 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06622395 clinical trial?
NCT06622395 is sponsored by Centre Hospitalier St Anne. The trial plans to enroll 137 participants.